# Pheon Therapeutics: Research, Harpenden, United Kingdom

> Pheon Therapeutics: Pheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treating...

Source: https://millionrounds.com/startup/pheon-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Research startup](https://millionrounds.com/companies)

# Pheon Therapeutics

Pheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treating hard-to-treat solid tumors and liquid cancers.

Funding reported Last round: Series B

Research Harpenden, United Kingdom

Company summary

- **Founded:** 2022 4 years old
- **Team:** 26 11 to 50 people
- **Funding reported:** 188M as listed, currency not stated
- **Last round:** Series B May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Pheon Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Pheon Therapeutics

Pheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treating hard-to-treat solid tumors and liquid cancers.

Founded in 2015 and headquartered in Harpenden, Hertfordshire, the company leverages two decades of ADC experience to create a novel pipeline of advanced cancer treatments. The company’s lead program features a first-in-class ADC targeting a novel antigen expressed in various solid tumors. Pheon Therapeutics utilizes clinically validated monoclonal antibodies combined with proprietary drug payloads to enhance treatment efficacy. With approximately 25 employees, the company operates within the drug discovery, biotechnology, and oncology sectors, primarily serving the healthcare industry. Pheon Therapeutics is backed by significant venture capital, having raised around $188–$191 million to date, with plans to submit an Investigational New Drug application to the US FDA in the near future.

## What company datasets say Pheon Therapeutics raised

Funding, as reported

Reported in all **188M** in the source's currency

Rounds **3**

Last round **Series B**

Last round size **120M**

Last round date **May 2024**

Investors listed **8**

## Funding filed with regulators

Pheon Therapeutics filed 4 raises, $150M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Oct 2025 **$60M** UK share allotment
- Apr 2024 **$60M** UK share allotment
- Mar 2024 **$15M** UK share allotment
- Oct 2023 **$15M** UK share allotment

## Founders and team

From Pheon Therapeutics's own website: 2 on the team.

- **Lawrence Cripe** Vice President, Business Development & Corporate Strategy
- **Myles Clancy** Vice President, Development Operations and Sciences

## The company, in detail

What they build

Known for

health care monoclonal antibodies antibody-drug conjugates payload platform clinical-stage adcs biotechnology research clinical biomarker profiling biomarker-driven development adc payload mechanisms medical research biotech investors oncology research cancer therapeutics cancer treatment pipeline biotech collaborations targeted therapy

Built with from their website

Google Maps parallax.js WordPress.org Neogov HRMS Max Mega Menu Viewport Meta Facebook SDK Apple Business Manager KnowBe4 Priority Hints

+8 more

Microsoft Exchange MySQL PrimeNG Microsoft 365 Apps & Services Mobile Friendly Wagtail CMS AWS Database Migration Service jQuery

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** England
- **Revenue:** 1M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/pheon-therapeutics)

## Research in United Kingdom

Startups like it

- [**Isomorphic Labs** London · founded 2021 *Raised*](https://millionrounds.com/company/isomorphic-labs)
- [**Basecamp Research** London · founded 2019 *Raised*](https://millionrounds.com/company/basecamp-research)
- [**Callosum** London · founded 2025 *Raised*](https://millionrounds.com/company/callosum)
- [**Artios** Babraham · founded 2016 *Raised*](https://millionrounds.com/company/artios)
- [**First Light Fusion** Yarnton · founded 2011 *Raised*](https://millionrounds.com/company/first-light-fusion)
- [**IMU Biosciences** London · founded 2019 *Raised*](https://millionrounds.com/company/imu-biosciences)
- [**Orbital Industries** London · founded 2022 *Raised*](https://millionrounds.com/company/orbital-industries)
- [**Genomics** Oxford · founded 2014 *Raised*](https://millionrounds.com/company/genomics)

## Is this your company?

Add your raise, your deck and your story, and put Pheon Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)